FAS and cancer: Recently, it was discovered that the Fas/APO-1 (CD95) receptor is an important cellular component responsible for the induction of apoptosis in leukemic cells and an important therapeutic target, because antibodies directed against this receptor were able to cause apoptosis in a variety of cancer cells.